CVE-2016-8355

9.9 CRITICAL
Published: February 13, 2017 Modified: May 13, 2026
View on NVD

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

AI Explanation

Get an AI-powered plain-language explanation of this vulnerability and remediation steps.

Login to generate AI explanation

CVSS v3.x Details

0.0 Low Medium High Critical 10.0
Vector String
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

References to Advisories, Solutions, and Tools

Patch Vendor Advisory Exploit Third Party Advisory
http://www.securityfocus.com/bid/94630
Source: ics-cert@hq.dhs.gov
Third Party Advisory VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
Source: ics-cert@hq.dhs.gov
Third Party Advisory US Government Resource
http://www.securityfocus.com/bid/94630
Source: af854a3a-2127-422b-91ae-364da2661108
Third Party Advisory VDB Entry
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
Source: af854a3a-2127-422b-91ae-364da2661108
Third Party Advisory US Government Resource

4 reference(s) from NVD

Quick Stats

CVSS v3 Score
9.9 / 10.0
EPSS (Exploit Probability)
1.5%
71th percentile
Exploitation Status
Not in CISA KEV

Weaknesses (CWE)

Affected Vendors

smiths-medical